Status | Study |
COMPLETED |
Study Name: Chia Seeds Consumption in Hypertriglyceridemia Condition: Hypertriglyceridemia Date: 2023-08-27 Interventions: Low-calorie diet with the use of placebo pearls (containing sunflower oil) |
NOT_YET_RECRUITING |
Study Name: Study of MAR001 in Adults With Metabolic Dysfunction Condition: Date: 2023-05-31 Interventions: Subcutaneous injection |
Completed |
Study Name: Metabolic Effects of Egg Protein and Unsaturated Fat Intakes in Subjects With Hypertriglyceridemia Condition: Hypertriglyceridemia Date: 2016-10-03 Interventions: Other: Egg protein/unsaturated fatty acid |
Not yet recruiting |
Study Name: Omega-3-Acid Ethyl Esters 90 Soft Capsules for Lowering Very High Triglycerides Condition: Hypertriglyceridemia Date: 2015-12-07 Interventions: Drug: Omega-3-Acid Ethyl Esters 90 Soft Capsules |
Completed |
Study Name: Effect of Therapeutic Phlebotomies on the Triglycerides Concentration in Patients With Hypertriglyceridemia and Hyperferritinemia Condition: Hyperferritinemia Hypertriglyceridemia Date: 2015-03-25 Interventions: Procedure: Phlebotomy Volume o |
Active, not recruiting |
Study Name: The COMPASS Study: A Study of Volanesorsen (Formally ISIS-APOCIIIRx) in Patients With Hypertriglyceridemia Condition: Hypertriglyceridemia Date: 2014-11-20 Interventions: Drug: volanesorsen 300 mg vola |
Recruiting |
Study Name: Hypertriglyceridaemia - Cause and Effects Condition: Hypertriglyceridaemia Date: 2014-07-10 |
Completed |
Study Name: Epanova® for Lowering Very High Triglycerides II (EVOLVE II) Condition: Hypertriglyceridemia Date: 2013-12-09 Interventions: Drug: Epanova Epanova will be |
Completed |
Study Name: Efficacy and Safety Study of DHA-O in Adults With Hypertriglyceridemia Condition: Hypertriglyceridemia Date: 2012-11-27 Interventions: Dietary Supplement: DHA-O Dietary Suppleme |
Completed |
Study Name: Safety, Tolerability, and Pharmacokinetic Study of ISIS ApoC-III Rx in Hypertriglyceridemia Condition: Hypertriglyceridemia Date: 2012-02-06 Interventions: Drug: ISIS apoC-III Rx Dose 1 |